Biosimilars and biopharmaceuticals: what the nephrologists need to know—a position paper by the ERA-EDTA Council

Saved in:

Bibliographic Details
Published in:	Nephrology, dialysis, transplantation Vol. 23; no. 12; pp. 3731 - 3737
Main Authors:	Covic, Adrian, Cannata-Andia, Jorge, Cancarini, Giovanni, Coppo, Rosanna, Frazão, João M., Goldsmith, David, Ronco, Pierre, Spasovski, Goce B., Stenvinkel, Peter, Utas, Cengiz, Wiecek, Andrzej, Zoccali, Carmine, London, Gerard
Format:	Journal Article
Language:	English
Published:	Oxford Oxford University Press 01-12-2008 Oxford Publishing Limited (England)
Subjects:	Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Animals Biological and medical sciences biopharmaceuticals Biopharmaceutics - legislation & jurisprudence Biopharmaceutics - standards Biopharmaceutics - trends biosimilars Drug Contamination Emergency and intensive care: renal failure. Dialysis management ERA-EDTA position paper Europe Glycosylation Guidelines as Topic Hematinics - standards Human Growth Hormone - standards Human viral diseases Humans Infectious diseases Intensive care medicine Medical sciences Medicin och hälsovetenskap Nephrology pharmacovigilance Recombinant Proteins - chemistry Recombinant Proteins - pharmacokinetics Recombinant Proteins - pharmacology Recombinant Proteins - standards Viral diseases Viral hepatitis Europe biopharmaceuticals ERA-EDTA position paper pharmacovigilance biosimilars Kidney disease Extrarenal dialysis Urinary system disease Hemodialysis Renal failure EDTA
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Bibliography:	ArticleID:gfn519 ark:/67375/HXZ-RS66SDSF-F istex:E2E466428BA784E12664166E3F6C3D0EB921E44C ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 SourceType-Other Sources-1 content type line 63 ObjectType-Editorial-2 ObjectType-Commentary-1
ISSN:	0931-0509 1460-2385 1460-2385
DOI:	10.1093/ndt/gfn519